Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to evaluate the prognostic significance of vitamin D status in hospitalized patients with ALD.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were excluded if they met any of the following criteria: (1) coexisting viral hepatitis, drug-induced liver injury, autoimmune liver disease, or other chronic liver diseases; (2) prior liver transplantation; (3) use of vitamin D supplements or medications known to affect serum vitamin D levels within the preceding 12 months; or (4) incomplete follow-up data.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Prognostic associations of vitamin D deficiency with disease severity, survival, and complications in alcohol-related liver disease

Study design awaiting verification · Frontiers in Medicine · 2026

Original publication title

Prognostic associations of vitamin D deficiency with disease severity, survival, and complications in alcohol-related liver disease

Qiufeng He; Fangfang Duan; Chuangjie Mao; Jun Cheng; Yazhi Wang; Yilan Zeng; Song Yang

Copyright © 2026 He, Duan, Mao, Cheng, Wang, Zeng and Yang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In this cohort of hospitalized ALD patients, vitamin D deficiency was associated with greater disease severity, reduced survival, and increased risk of sarcopenia and SBP. Serum 25(OH)D may serve as a prognostic marker of overall disease burden. Given the retrospective design, limited event numbers, and short follow-up, these findings should be considered exploratory and require confirmation in prospective studies.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Vitamin D deficiency has been associated with adverse outcomes in various chronic diseases, and its relevance in alcohol-related liver disease (ALD) has attracted increasing attention. This study aimed to evaluate the prognostic significance of vitamin D status in hospitalized patients with ALD.

Source: Background

Abstract: What methods does the paper describe?

We retrospectively analyzed 115 hospitalized patients with ALD between 2021 and 2024. Vitamin D deficiency was defined as serum 25-hydroxyvitamin D [25(OH)D] < 20 ng/mL. Statistical analyses were performed using Spearman’s correlation, logistic regression, Kaplan: Meier survival analysis, multivariable Cox proportional hazards models, and receiver operating characteristic (ROC) curve analysis.

Source: Methods

Abstract: Results

Vitamin D deficiency was present in 35.7% of patients. After adjustment for season, vitamin D deficiency was associated with alcoholic hepatitis, cirrhosis, ascites, sarcopenia, total bilirubin, Model for End-Stage Liver Disease score, and Maddrey discriminant function ≥ 32 (all p < 0.05). In multivariable logistic regression, vitamin D deficiency independently predicted greater disease severity (OR 3.087, 95% CI 1.034 to 9.215; p = 0.043). Kaplan: Meier analysis showed reduced survival among patients with vitamin D deficiency (log-rank p = 0.025), and multivariable Cox regression confirmed vitamin D deficiency as an independent predictor of mortality (HR 3.179, 95% CI 1.064 to 9.500; p = 0.038).

ROC analyses indicated modest discrimination of serum 25(OH)D for sarcopenia and spontaneous bacterial peritonitis (SBP), with optimal cut-offs of 22.74 and 14.2 ng/mL, respectively.

Source: Results

Abstract: Conclusion

In this cohort of hospitalized ALD patients, vitamin D deficiency was associated with greater disease severity, reduced survival, and increased risk of sarcopenia and SBP. Serum 25(OH)D may serve as a prognostic marker of overall disease burden. Given the retrospective design, limited event numbers, and short follow-up, these findings should be considered exploratory and require confirmation in prospective studies.

Source: Conclusion
Authors’ abstract

Background

Vitamin D deficiency has been associated with adverse outcomes in various chronic diseases, and its relevance in alcohol-related liver disease (ALD) has attracted increasing attention. This study aimed to evaluate the prognostic significance of vitamin D status in hospitalized patients with ALD.

Methods

We retrospectively analyzed 115 hospitalized patients with ALD between 2021 and 2024. Vitamin D deficiency was defined as serum 25-hydroxyvitamin D [25(OH)D] < 20 ng/mL. Statistical analyses were performed using Spearman’s correlation, logistic regression, Kaplan: Meier survival analysis, multivariable Cox proportional hazards models, and receiver operating characteristic (ROC) curve analysis.

Results

Vitamin D deficiency was present in 35.7% of patients. After adjustment for season, vitamin D deficiency was associated with alcoholic hepatitis, cirrhosis, ascites, sarcopenia, total bilirubin, Model for End-Stage Liver Disease score, and Maddrey discriminant function ≥ 32 (all p < 0.05). In multivariable logistic regression, vitamin D deficiency independently predicted greater disease severity (OR 3.087, 95% CI 1.034 to 9.215; p = 0.043). Kaplan: Meier analysis showed reduced survival among patients with vitamin D deficiency (log-rank p = 0.025), and multivariable Cox regression confirmed vitamin D deficiency as an independent predictor of mortality (HR 3.179, 95% CI 1.064 to 9.500; p = 0.038).

ROC analyses indicated modest discrimination of serum 25(OH)D for sarcopenia and spontaneous bacterial peritonitis (SBP), with optimal cut-offs of 22.74 and 14.2 ng/mL, respectively.

Conclusion

In this cohort of hospitalized ALD patients, vitamin D deficiency was associated with greater disease severity, reduced survival, and increased risk of sarcopenia and SBP. Serum 25(OH)D may serve as a prognostic marker of overall disease burden. Given the retrospective design, limited event numbers, and short follow-up, these findings should be considered exploratory and require confirmation in prospective studies.

Publication and source details

Original title: Prognostic associations of vitamin D deficiency with disease severity, survival, and complications in alcohol-related liver disease

Qiufeng He; Fangfang Duan; Chuangjie Mao; Jun Cheng; Yazhi Wang; Yilan Zeng; Song Yang

Frontiers in Medicine · 2026

* Correspondence: Song Yang, duyangsong@163.comYilan Zeng, zhyilan991827@163.com
†

These authors have contributed equally to this work

Copyright © 2026 He, Duan, Mao, Cheng, Wang, Zeng and Yang.2026He, Duan, Mao, Cheng, Wang, Zeng and Yanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:33:35.135324+00:00

DOI: 10.3389/fmed.2026.1777280 · PMC13050956